title: NICE rules that drug used in advanced liver cancer is not cost effective for the NHS.
authors.forename: Susan
authors.initials: S
authors.lastname: Mayor
mesh_terms: D000970:Antineoplastic Agents / Q000191:economics*; D001557:Benzenesulfonates / Q000191:economics*; D003362:Cost-Benefit Analysis; D006801:Humans; D008113:Liver Neoplasms / Q000188:drug therapy* / Q000191:economics; D009536:Niacinamide / Q000031:analogs & derivatives; D010671:Phenylurea Compounds; D011725:Pyridines / Q000191:economics*; D019057:Quality-Adjusted Life Years; D000077157:Sorafenib; D006113:United Kingdom
chemical_list: D000970:Antineoplastic Agents; D001557:Benzenesulfonates; D010671:Phenylurea Compounds; D011725:Pyridines; D009536:Niacinamide; D000077157:Sorafenib